| Patents for C07D 207 - Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom (40,304) |
|---|
| 05/08/2008 | WO2008053319A1 Amide resorcinol compounds |
| 05/08/2008 | WO2008053312A2 Process for preparing amorphous atorvastatin hemi calcium salt and its intermediate |
| 05/08/2008 | WO2008052788A1 [f-18]-labeled l-glutamic acid, [f-18]-labeled l-glutamine, derivatives thereof and use thereof and processes for their preparation |
| 05/08/2008 | WO2008024302A8 Compounds for treating proliferative disorders |
| 05/08/2008 | WO2007117591A3 Total synthesis of salinosporamide a and analogs thereof |
| 05/08/2008 | WO2007039749A3 Antibacterial pyrrols |
| 05/08/2008 | US20080108830 Reacting thionyl chloride with 2-amino-5-chlorobenzophenone to give 2-[(N-benzylprolyl)amino]-5-chlorobenzophenone; useful as a chiral auxiliary for the synthesis of an optically active amino acid; high purity and high yield |
| 05/08/2008 | US20080108820 First isolated from the sponge Hemiasterella; for treatment of cancer; prevention of restenosis of blood vessels subject to traumas such as angioplasty and stenting; methods for synthetic preparation |
| 05/08/2008 | US20080108691 For example, 1-(4-Cyano-2-ethyl-3-(trifluoromethyl)phenyl-1-carbamoyl)-3-hydroxy-pyrrolidine-2-carboxylic acid methyl ester; may be used in treatment of diseases or disorders associated with androgen receptor activity, such as maintenance of muscle strength and function in the elderly |
| 05/08/2008 | US20080108604 sugar transport enhancement agent; antidiabetic and hypoglycemic agent; obesity, diabetic nephropathy, retinopathy, macrovascular disease, glucose tolerance anomaly; cyclization of 4-(2-aminocyclohexylamino)-3-pyrroline-2-one by aldehyde followed by acylation |
| 05/08/2008 | US20080108601 anticancer agents; catalytic hydrogenation |
| 05/08/2008 | US20080108594 Antithrombotic Ethers |
| 05/08/2008 | US20080108523 Acid ammonium salts of an imide of polymaleic anhydride; hydraulic fracturing fluids used in enhanced oil recovery; subterranean formations |
| 05/08/2008 | CA2667961A1 Mapk/erk kinase inhibitors |
| 05/08/2008 | CA2667920A1 Process for preparing indol-5-oxy-quinazoline derivatives and intermediates |
| 05/08/2008 | CA2667395A1 [f-18]-labeled l-glutamic acid, [f-18]-labeled l-glutamine, their derivatives and their use and processes for their preparation |
| 05/08/2008 | CA2665007A1 Non-nucleoside reverse transcriptase inhibitors |
| 05/07/2008 | EP1918276A1 Production method of optically active 2- [ (N-Benzylprolyl) Amino ] Benzophenone compound |
| 05/07/2008 | EP1918275A1 Production method of diphenylalanine - NI(II) complex |
| 05/07/2008 | EP1918272A1 Pharmaceutically active compounds and methods of use |
| 05/07/2008 | EP1603874B1 G-lactam derivatives as prostaglandin agonists |
| 05/07/2008 | EP1390347B1 Pyrrolidine ester derivatives with oxytocin modulating activity |
| 05/07/2008 | CN101175748A N,n-substituted 3-aminopyrrolidine compounds useful as monoamines reuptake inhibitors |
| 05/07/2008 | CN101175747A Substituted N-arylpyrrolidines as selective androgen receptor modulators |
| 05/07/2008 | CN101175724A Pyrrolidine derivative or salt thereof |
| 05/07/2008 | CN101175723A 1,2-di(cyclic) substituted benzene compounds |
| 05/07/2008 | CN101172983A Substituted phenylacetic acids |
| 05/07/2008 | CN101172930A 2.4-dihalogen-6-(C2-C3-alkyl)-phenyl substituted tetramic acid derivatives |
| 05/07/2008 | CN100386316C Mixtures and compounds from Antrodia camphorate myceliums and use thereof |
| 05/07/2008 | CN100386315C Preparation method of N-substituted imide |
| 05/06/2008 | US7368568 Protected 3,5-dihydroxy-2,2-dimethyl-valeroamides for the synthesis of epothilones and derivatives and process for production and the use |
| 05/06/2008 | US7368479 Alpha-sulfonylamino-acetonitriles |
| 05/06/2008 | US7368462 4'-Fluoro-biphenyl-4-carboxylic acid (6-dimethylaminomethyl-naphthalen-1-ylmethyl)-amide; obesity; side effects reduction; selective binding; no stimulation of the central nervous system and no peripheral activity caused by activation of 5-HT2c receptors; improved cellular potency and pharmacokinetics |
| 05/06/2008 | US7368421 Use of dipeptidyl peptidase IV inhibitors in the treatment of multiple sclerosis |
| 05/06/2008 | US7368415 Substituted beta-(oxazolidin-3-ylcarbonyl)styrenes: 1-[2-(2,4-Dimethyl-cyclohex-3-enyl)-oxazolidin-3-yl]-3-(2-hydroxy-phenyl)-propenone; for delivering fragrances to a laundary detergent, shampoo or hair conditioner |
| 05/06/2008 | CA2440331C Atorvastatin calcium in a pharmaceutical form, composition thereof, and pharmaceutical formulation comprising atorvastatin calcium |
| 05/06/2008 | CA2430601C Piperazine derivatives |
| 05/06/2008 | CA2244979C Proton conductor in liquid form |
| 05/02/2008 | WO2008051887A1 Process for preparing 5-alkyl-7h-pyrrolo[2,3-d]pyrimidine-2-ols |
| 05/02/2008 | WO2008051047A1 Aminopyrazole derivatives, process for the preparation thereof, and composition for preventing or treating ischemic diseases containing the same |
| 05/02/2008 | WO2008050857A1 Amide compound or salt thereof, and biofilm formation inhibitor, biofilm remover and bactericide each using the amide compound or salt thereof |
| 05/02/2008 | WO2008050570A1 Method for producing succinimide compound |
| 05/02/2008 | WO2008050168A1 New sulfonamide derivatives as bradykinin antagonists |
| 05/02/2008 | WO2008049808A1 Mtp inhibiting tetrahydro-naphthalene-1-carboxylic acid derivatives |
| 05/02/2008 | WO2007150010A3 Cyclopropyl amine derivatives as histamin h3 receptor modulators |
| 05/02/2008 | WO2007144503A3 Novel process for preparing nitrones and n-hydroxylamines comprising at least one hydroxyl group, and products thus obtained |
| 05/02/2008 | CA2667267A1 Process for preparing 5-alkyl-7h-pyrrolo[2,3-d]pyrimidine-2-ols |
| 05/02/2008 | CA2664143A1 Mtp inhibiting tetrahydro-naphthalene-1-carboxylic acid derivatives |
| 05/01/2008 | US20080103191 Entacapone-derivatives |
| 05/01/2008 | US20080102042 Dentifrices containing N-acyl derivative of hydroxyproline; periodontal disease |
| 05/01/2008 | US20080101989 Methods, Compositions and Kits Pertaining to Analyte Determination |
| 04/30/2008 | EP1915994A1 Cyclic amine derivative containing ppar regulator |
| 04/30/2008 | EP1915382A2 Hepatitis c serine protease inhibitors and uses therefor |
| 04/30/2008 | EP1915340A2 Synthetic processes for the preparation of aminocyclohexyl ether compounds |
| 04/30/2008 | CN101171230A Heterocyclic-substituted alkanamides useful as renin inhibitors |
| 04/30/2008 | CN101168523A Method for overturning syn-form 4-alkyl-N-tert-butoxycarbonyl pyroglutamic acid ester to anti-form product |
| 04/30/2008 | CN100384889C Polymerization of olefins |
| 04/30/2008 | CN100384821C Cetp activity inhibitors |
| 04/30/2008 | CN100384819C Peptide inhibitors of SMAC protein binding to inhibitor of apoptosis proteins (IAP) |
| 04/29/2008 | US7365196 Sulphonamido-substituted bridged bicycloalkyl derivatives |
| 04/29/2008 | US7365094 Rheumatic diseases; antiarthritic agents; autoimmune disorders ; antiproliferative agents; antiinflammatory agents; antiprotozoa agents |
| 04/29/2008 | US7365092 Inhibitors of serine proteases, particularly HCV NS3-NS4A protease |
| 04/29/2008 | US7365076 for the prevention and treatment of conditions ameliorated by monoamine reuptake including, inter alia, vasomotor symptoms (VMS), sexual dysfunction, gastrointestinal and genitourinary disorders, chronic fatigue syndrome, fibromylagia syndrome, nervous system disorders |
| 04/29/2008 | US7365070 Such as N-{2-[2-(5-Bromo-2-methoxy-phenyl)-ethyl]-3-fluoro-benzoyl}-N'-butyl-guanidine; involuntary weight loss disorders |
| 04/29/2008 | CA2321188C Derivatives of azetidine and pyrrolidine |
| 04/29/2008 | CA2259203C Method for the synthesis of amines and amino acids with organoboron derivatives |
| 04/29/2008 | CA2254833C Pharmaceutical for treatment of neurological and neuropsychiatric disorders |
| 04/24/2008 | WO2008048987A1 Processes suitable for producing macromolecular antioxidant compositions |
| 04/24/2008 | WO2008048609A1 Biphenyl sulfonyl and phenyl-heteroaryl sulfonyl modulators of the histamine h3-receptor useful for the treatment of disorders related thereto |
| 04/24/2008 | WO2008046889A1 Enantiomer-enriched alpha-,omega amino alcohol derivatives, their production and use as insect- and mite-repelling agents |
| 04/24/2008 | US20080097109 2-oxo-1-pyrrolidine derivatives, processes for preparing them and their uses |
| 04/24/2008 | US20080097098 4,5-methyl-7H-pyrrolo[2,3-d]pyrimidin-4-ol; |
| 04/24/2008 | US20080097061 Oxylamino Group-Containing Compound and Polymer |
| 04/24/2008 | US20080096960 4-amino-3-(4-chlorophenyl)butanoic acid; prodrugs of baclofen and baclofen analogs; gamma aminobutanoic acid agonist; drug, nicotine, and narcotic abuse; antitussive, antiemetic agent; cough, nausea, vomiting; oral administration; sustained release dosage form |
| 04/24/2008 | US20080096957 Albumin-Binding Conjugates Comprising a Fatty Acid and Peg |
| 04/24/2008 | US20080096956 Protection of a plant against attack by a phytopathogenic organism or treatment of a plant infested by a phytopathogenic organism, comprising applying malonomicin derivative to soil, a plant, a part of a plant, foliage, and/or seeds |
| 04/24/2008 | US20080096936 Sulfur substituted sulfonylaminocarboxylic acid N-arylamides, their preparation, their use and pharmaceutical preparations comprising them |
| 04/24/2008 | US20080096934 N-[4-((S)-2-Propylamino-propyl)-phenyl]-4-trifluoromethoxy-benzenesulfonamide; Dipropyl-{2-[4-(4-trifluoromethoxy-benzenesulfonylmethyl)-phenyl]-ethyl}-dipropyl-amine salt, psychological, nervous system disorders such as schizophernia, bipolar, dyskinesias, tourette syndrome, depression, sleep disorder |
| 04/24/2008 | US20080096908 Nitrate derivatives of atorvastatin with improved pharmacological activity and enhanced tolerability; coronary syndromes, neurodegenerative disorders, and for reducing cholesterol levels; antiinflammatory, antithrombotic and antiplatelet activity; fluvastatin 4-(nitrooxy)butyl ester |
| 04/24/2008 | US20080096903 inhibitors of disease-related target, Heat Shock Protein 90 (HSP90); antiproliferative; 2-chloro-5'-sulfamoyladenosine analogs; derivatives of adenine and other purines; Sulfamic Acid 2-[6-amino-2-fluoro-8-(6-iodo-benzo[1,3]dioxol-5-ylmethyl)-purin-9-yl]-ethyl ester |
| 04/24/2008 | US20080096869 Adamantyl acetamides as 11-beta hydroxysteroid dehydrogenase inhibitors |
| 04/24/2008 | US20080096848 Substituted N-Aryl-9-Oxo-9H-Fluorene-1-Carboxamides and Analogs as Activators of Caspases and Inducers of Apoptosis |
| 04/24/2008 | CA2666878A1 Enantiomer-enriched alpha-,omega amino alcohol derivatives, their production and use as insect- and mite-repelling agents |
| 04/24/2008 | CA2665204A1 Biphenyl sulfonyl and phenyl-heteroaryl sulfonyl modulators of the histamine h3-receptor useful for the treatment of disorders related thereto |
| 04/24/2008 | CA2665011A1 Alkylated heterocyclic reaction products useful as antioxidants |
| 04/23/2008 | EP1912938A2 Salts of vildagliptin |
| 04/23/2008 | EP1912662A2 Peptide deformylase inhibitors |
| 04/23/2008 | EP1828082B1 Method for cleaning deposits from equipment that have accumulated during a method for recovering nmp by the introduction of hot water and agitation |
| 04/23/2008 | EP1421827A4 Organic light emitting devices having carrier blocking layers comprising metal complexes |
| 04/23/2008 | EP1303483B1 Novel thiourea derivatives and the pharmaceutical compositions containing the same |
| 04/23/2008 | EP1007033B1 Lymphocyte function antigen-1 antagonists |
| 04/23/2008 | CN101166737A Phosphodiesterase 4 inhibitors |
| 04/23/2008 | CN101166720A Activator for peroxisome proliferator activating receptor delta |
| 04/23/2008 | CN101166719A Bcrp/abcg2抑制剂 Bcrp / abcg2 inhibitors |
| 04/23/2008 | CN101166718A Androgen modulators |
| 04/23/2008 | CN101166717A N-alkenylcarboxylic acid tertiary amide composition |
| 04/23/2008 | CN101165048A Method for preparing polyisocyanic acid ester |
| 04/23/2008 | CN100383120C Method for preparing chiral disubstituted or alpha, alpha'-double instituted N-acylpyrrolidine or N-acylpiperidine |
| 04/23/2008 | CN100383118C 4-pyrrolidino-phenyl-benzyl ether derivatives |
| 04/22/2008 | US7361772 Process for the production of atorvastatin calcium |